Apeloa Pharmaceutical Co Ltd (000739) — Financial Flexibility Index
Apeloa Pharmaceutical Co Ltd (000739) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥612.91 Million (operating CF CN¥446.18 Million minus capex CN¥166.73 Million) represents 0% of total liabilities (CN¥5.97 Billion). Also explore Apeloa Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Apeloa Pharmaceutical Co Ltd across 28 annual periods. Check 000739 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Apeloa Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Apeloa Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥1.62 Billion | CN¥1.23 Billion | CN¥5.97 Billion | ▼ -3.0% |
| 2024 | 0.28x | CN¥1.67 Billion | CN¥1.21 Billion | CN¥5.98 Billion | ▲ +9.8% |
| 2023 | 0.25x | CN¥1.66 Billion | CN¥1.03 Billion | CN¥6.54 Billion | ▼ -9.9% |
| 2022 | 0.28x | CN¥1.84 Billion | CN¥1.33 Billion | CN¥6.50 Billion | ▼ -14.4% |
| 2021 | 0.33x | CN¥1.31 Billion | CN¥611.75 Million | CN¥3.98 Billion | ▼ -25.7% |
| 2020 | 0.44x | CN¥1.38 Billion | CN¥1.06 Billion | CN¥3.10 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥1.39 Billion | CN¥1.36 Billion | CN¥2.75 Billion | ▲ +33.0% |
| 2018 | 0.38x | CN¥914.32 Million | CN¥832.69 Million | CN¥2.41 Billion | ▲ +168.9% |
| 2017 | 0.14x | CN¥373.22 Million | CN¥209.80 Million | CN¥2.64 Billion | ▼ -17.1% |
| 2016 | 0.17x | CN¥511.77 Million | CN¥180.42 Million | CN¥3.00 Billion | ▼ -43.2% |
| 2015 | 0.30x | CN¥893.23 Million | CN¥441.16 Million | CN¥2.98 Billion | ▼ -37.7% |
| 2014 | 0.48x | CN¥1.33 Billion | CN¥786.64 Million | CN¥2.76 Billion | ▲ +94.2% |
| 2013 | 0.25x | CN¥695.45 Million | CN¥190.45 Million | CN¥2.80 Billion | ▲ +0.6% |
| 2012 | 0.25x | CN¥675.49 Million | CN¥335.90 Million | CN¥2.74 Billion | ▼ -14.9% |
| 2011 | 0.29x | CN¥693.83 Million | CN¥404.62 Million | CN¥2.40 Billion | ▲ +15.0% |
| 2010 | 0.25x | CN¥260.85 Million | CN¥121.05 Million | CN¥1.04 Billion | ▼ -20.4% |
| 2009 | 0.32x | CN¥301.95 Million | CN¥208.30 Million | CN¥954.91 Million | ▼ -30.6% |
| 2008 | 0.46x | CN¥443.61 Million | CN¥94.57 Million | CN¥973.00 Million | ▲ +35.9% |
| 2007 | 0.34x | CN¥289.90 Million | CN¥174.20 Million | CN¥864.02 Million | ▲ +30.4% |
| 2006 | 0.26x | CN¥213.27 Million | CN¥159.43 Million | CN¥828.68 Million | ▼ -9.8% |
| 2005 | 0.29x | CN¥209.05 Million | CN¥87.40 Million | CN¥732.94 Million | ▲ +33.7% |
| 2004 | 0.21x | CN¥158.61 Million | CN¥47.54 Million | CN¥743.40 Million | ▼ -41.1% |
| 2003 | 0.36x | CN¥193.45 Million | CN¥105.36 Million | CN¥534.24 Million | ▲ +186.2% |
| 2002 | 0.13x | CN¥50.05 Million | CN¥2.81 Million | CN¥395.59 Million | ▲ +8937.8% |
| 2001 | 0.00x | CN¥458.70K | CN¥-569.79K | CN¥327.67 Million | ▼ -97.6% |
| 2000 | 0.06x | CN¥10.30 Million | CN¥7.08 Million | CN¥177.79 Million | ▲ +196.7% |
| 1999 | -0.06x | CN¥-12.72 Million | CN¥-20.52 Million | CN¥212.40 Million | ▼ -129.2% |
| 1998 | 0.20x | CN¥46.53 Million | CN¥30.10 Million | CN¥227.17 Million | — |